SRI’s Clinical Trials Unit is conducting clinical research studies evaluating investigational treatments that may help reduce seizures in adults with focal epilepsy.

General eligibility criteria:

•  Adults age 18 to 75
•  Male or female participants
•  Confirmed diagnosis of focal epilepsy
•  Currently taking one to three antiseizure medications and continuing to experience seizures

 

Individuals who meet these general criteria may be considered for one or more clinical research studies. If you are interested in learning more, please complete the interest form. A member of the research team will contact you with additional information.

 

*Privacy notice:
By completing this form, you consent to SRI’s Clinical Trial Unit securely storing your information in our research database. Your information may be used to determine eligibility for current or future clinical studies. You may request to have your information removed from our database at any time by contacting the research team at clinical-trials@sri.com.